How many studies have been conducted on Ethylketocyclazocine?

BiohacksAI has indexed 300 PubMed studies on Ethylketocyclazocine. 2% of studies involve human subjects.

What are the main research areas for Ethylketocyclazocine?

The primary research domains for Ethylketocyclazocine are 💊 Pain, 🏋️ Muscle & Hypertrophy, 🧠 Learning. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Ethylketocyclazocine

A kappa opioid receptor agonist. The compound has analgesic action and shows positive inotropic effects on the electrically stimulated left atrium. It also affects various types of behavior in mammals such as locomotion, rearing, and grooming.

300+ PubMed studies analyzed · Evidence Score: 40.9

Research Domains

Ethylketocyclazocine has been studied across 18 research domains including 💊 Pain, 🏋️ Muscle & Hypertrophy, 🧠 Learning, 🧠 Focus & Attention, 😴 Sleep. The primary research focus is 💊 Pain with 90% of studies addressing this area.

Loading evidence profile...

This evidence profile for Ethylketocyclazocine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.